Aquestive Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14.4M | 13.0M | 12.8M | 10.0M | 8.7M | 11.9M | 13.5M | 20.1M |
| Cost of Goods Sold | 3.5M | 5.8M | 4.5M | 4.6M | 3.7M | 4.5M | 4.4M | 4.5M |
| Gross Profit | 11.0M | 7.2M | 8.3M | 5.4M | 5.1M | 7.3M | 9.1M | 15.6M |
| R&D Expenses | 4.2M | 3.2M | 4.5M | 4.1M | 5.4M | 4.9M | 5.3M | 4.2M |
| Operating Expenses | 15.2M | 36.0M | 19.8M | 16.8M | 24.4M | 20.9M | 17.4M | 15.5M |
| Operating Income | -4.2M | -28.8M | -11.5M | -11.4M | -19.4M | -13.6M | -8.3M | 55K |
| Other Income / Gains | -3.9M | -3.0M | -4.0M | -2.2M | -3.6M | -3.5M | -3.2M | -2.8M |
| Net Income | -8.1M | -31.9M | -15.4M | -13.5M | -22.9M | -17.1M | -11.5M | -2.7M |
| EPS (Diluted) | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.76 | 0.552 | 0.648 | 0.544 | 0.581 | 0.619 | 0.672 | 0.775 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 11.0M | 32.8M | 15.3M | 12.7M | 19.1M | 16.0M | 12.1M | 11.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 18.6M | 41.9M | 24.3M | 21.4M | 28.1M | 25.4M | 21.8M | 20.0M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 734K | 979K | 1.4M |
| Interest Expense | 3.9M | 4.3M | 4.3M | 4.3M | 4.3M | 4.2M | 4.2M | 4.2M |
| Depreciation And Amortization | 119K | 130K | 139K | 140K | 139K | 147K | 159K | 205K |
| Ebitda | -4.0M | -27.5M | -11.0M | -9.1M | -18.5M | -12.7M | -7.2M | 1.7M |
| Ebitdaratio | -0.277 | -2.11 | -0.862 | -0.913 | -2.123 | -1.07 | -0.528 | 0.082 |
| Operating Income Ratio | -0.291 | -2.216 | -0.896 | -1.136 | -2.221 | -1.144 | -0.612 | 0.003 |
| Income Before Tax | -8.1M | -31.9M | -15.4M | -13.5M | -22.9M | -17.1M | -11.5M | -2.7M |
| Income Before Tax Ratio | -0.558 | -2.448 | -1.206 | -1.354 | -2.63 | -1.438 | -0.85 | -0.137 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | -14K | 0 | 0 |
| Net Income Ratio | -0.558 | -2.448 | -1.206 | -1.354 | -2.63 | -1.437 | -0.85 | -0.137 |
| Epsdiluted | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 |
| Weighted Average Shs Out | 122.6M | 122.0M | 110.6M | 99.3M | 95.5M | 91.2M | 91.1M | 90.9M |
| Weighted Average Shs Out Dil | 122.6M | 122.0M | 110.6M | 99.3M | 95.5M | 91.2M | 91.1M | 90.9M |